Patients remain cancer-free nearly 3 years after receiving experimental immunotherapy
All participants in a trial of bowel cancer patients remain cancer-free almost three years after receiving an experimental treatment. The study, led by researchers at University College London and UCL Hospitals, suggests that for some patients, a short course of immunotherapy before surgery may produce better results than the current standard of care. The trial…